{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T23:07:03Z","timestamp":1778972823902,"version":"3.51.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000286","name":"The British Academy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000286","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018957","name":"Cara","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejpb.2026.115079","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T23:09:06Z","timestamp":1777590546000},"page":"115079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Mechanistic insights into dissolution of highly drug-loaded amorphous solid dispersions of a fast-crystallising drug"],"prefix":"10.1016","volume":"224","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2682-0360","authenticated-orcid":false,"given":"Tetiana","family":"Kolisnyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8771-3470","authenticated-orcid":false,"given":"Valentyn","family":"Mohylyuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115079_b0005","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1007\/s11095-009-0021-1","article-title":"Understanding the behavior of amorphous pharmaceutical systems during dissolution","volume":"27","author":"Alonzo","year":"2010","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115079_b0010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jconrel.2017.04.015","article-title":"Mechanism-based selection of stabilization strategy for amorphous formulations: Insights into crystallization pathways","volume":"256","author":"Edueng","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115079_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125331","article-title":"Stability and recrystallization of amorphous solid dispersions prepared by hot-melt extrusion and spray drying","volume":"672","author":"Martynek","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0020","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1208\/s12248-021-00598-6","article-title":"Amorphous Solid Dispersions Containing Residual Crystallinity: Competition Between Dissolution and Matrix Crystallization","volume":"23","author":"Moseson","year":"2021","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2026.115079_b0025","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.apsb.2013.11.001","article-title":"Fundamental aspects of solid dispersion technology for poorly soluble drugs","volume":"4","author":"Huang","year":"2014","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.ejpb.2026.115079_b0030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11095-017-2316-y","article-title":"Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions","volume":"35","author":"Lehmkemper","year":"2018","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115079_b0035","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.xphs.2022.08.007","article-title":"Considerations in the Development of Physically Stable High Drug Load API- Polymer Amorphous Solid Dispersions in the Glassy State","volume":"112","author":"Newman","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115079_b0040","doi-asserted-by":"crossref","first-page":"2963","DOI":"10.1007\/s11095-023-03547-4","article-title":"The Implications of Drug-Polymer Interactions on the Physical Stability of Amorphous Solid Dispersions","volume":"40","author":"Bookwala","year":"2023","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115079_b0045","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1002\/jps.22074","article-title":"Drug-polymer solubility and miscibility: Stability consideration and practical challenges in amorphous solid dispersion development","volume":"99","author":"Qian","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115079_b0050","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1021\/acs.molpharmaceut.1c00141","article-title":"Analytical and Computational Methods for the Determination of Drug-Polymer Solubility and Miscibility","volume":"18","author":"Thakore","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.125095","article-title":"High drug-loaded amorphous solid dispersions of a poor glass forming drug: The impact of polymer type and cooling rate on amorphous drug behaviour","volume":"670","author":"Kolisnyk","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0060","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1021\/acs.molpharmaceut.3c00020","article-title":"Dissolution Mechanisms of Amorphous Solid Dispersions: A Close Look at the Dissolution Interface","volume":"20","author":"Deac","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0065","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1021\/acs.molpharmaceut.8b01261","article-title":"Insights into the Dissolution Mechanism of Ritonavir-Copovidone Amorphous Solid Dispersions: Importance of Congruent Release for Enhanced Performance","volume":"16","author":"Indulkar","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0070","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.xphs.2022.03.020","article-title":"Formulation and Processing Strategies which Underpin Susceptibility to Matrix Crystallization in Amorphous Solid Dispersions","volume":"112","author":"Moseson","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115079_b0075","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1021\/acs.molpharmaceut.9b01272","article-title":"Congruent Release of Drug and Polymer from Amorphous Solid Dispersions: Insights into the Role of Drug-Polymer Hydrogen Bonding, Surface Crystallization, and Glass Transition","volume":"17","author":"Saboo","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2020.105514","article-title":"Patterns of drug release as a function of drug loading from amorphous solid dispersions: A comparison of five different polymers","volume":"155","author":"Saboo","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115079_b0085","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2019.01.039","article-title":"Congruent release of drug and polymer: A \u201csweet spot\u201d in the dissolution of amorphous solid dispersions","volume":"298","author":"Saboo","year":"2019","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejpb.2026.115079_b0090","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.xphs.2022.10.021","article-title":"Release Mechanisms of Amorphous Solid Dispersions: Role of Drug-Polymer Phase Separation and Morphology","volume":"112","author":"Yang","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115079_b0095","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1021\/acs.molpharmaceut.1c00419","article-title":"Impact of Drug-Polymer Intermolecular Interactions on Dissolution Performance of Copovidone-Based Amorphous Solid Dispersions","volume":"18","author":"Que","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0100","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15051539","article-title":"Thermodynamic Modeling of the Amorphous Solid Dispersion-Water Interfacial Layer and Its Impact on the Release Mechanism","volume":"15","author":"Dohrn","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115079_b0105","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/j.xphs.2022.12.019","article-title":"Improving Dissolution Performance and Drug Loading of Amorphous Dispersions Through a Hierarchical Particle Approach","volume":"112","author":"Hiew","year":"2023","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115079_b0110","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.xphs.2024.09.020","article-title":"The importance of surface composition and wettability on the dissolution performance of high drug loading amorphous dispersion formulations","volume":"114","author":"Hiew","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115079_b0115","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.jct.2016.08.020","article-title":"Binding thermodynamics of Diclofenac and Naproxen with human and bovine serum albumins: A calorimetric and spectroscopic study","volume":"103","author":"Bou-Abdallah","year":"2016","journal-title":"J. Chem. Thermodyn."},{"key":"10.1016\/j.ejpb.2026.115079_b0120","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1021\/ac300087z","article-title":"Measurement of drug lipophilicity and pKa using acoustics","volume":"84","author":"Li","year":"2012","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ejpb.2026.115079_b0125","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.aca.2005.06.058","article-title":"Critical validation of a new simpler approach to estimate aqueous pKa of drugs sparingly soluble in water","volume":"550","author":"Ruiz","year":"2005","journal-title":"Anal. Chim. Acta"},{"key":"10.1016\/j.ejpb.2026.115079_bib276","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1023\/A:1016212804288","article-title":"A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability","volume":"12","author":"Amidon","year":"1995","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115079_bib277","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1023\/A:1018947113238","article-title":"Estimating the fraction dose absorbed from suspensions of poorly soluble compounds in humans: a mathematical model","volume":"10","author":"Oh","year":"1993","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115079_b0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.xphs.2024.06.023","article-title":"Quantification of soluplus for dissolution tests: SEC method development and validation","volume":"114","author":"Horvath","year":"2025","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115079_b0135","series-title":"Naproxen Tablets (Monograph)","author":"British Pharmacopoeia","year":"2025"},{"key":"10.1016\/j.ejpb.2026.115079_b0140","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1021\/mp500412d","article-title":"Influence of copolymer composition on the phase behavior of solid dispersions","volume":"11","author":"Prudic","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0145","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1016\/S0032-3861(02)00235-5","article-title":"The measurement of the crystallinity of polymers by DSC","volume":"43","author":"Kong","year":"2002","journal-title":"Polymer"},{"key":"10.1016\/j.ejpb.2026.115079_b0150","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/pol.20210813","article-title":"Nucleation and crystallization kinetics of polyamide 12 investigated by fast scanning calorimetry","volume":"60","author":"Zhang","year":"2021","journal-title":"J. Polym. Sci."},{"key":"10.1016\/j.ejpb.2026.115079_b0155","series-title":"Semi-Crystalline Copolymer Hydrogels as Smart Drug Carriers","first-page":"13","author":"Ilic-Stojanovic","year":"2021"},{"key":"10.1016\/j.ejpb.2026.115079_b0160","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1021\/mp3003495","article-title":"Relating hydrogen-bonding interactions with the phase behavior of naproxen\/PVP K 25 solid dispersions: evaluation of solution-cast and quench-cooled films","volume":"9","author":"Paudel","year":"2012","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2023.123048","article-title":"FTIR, Raman spectroscopy and HT-XRD in compatibility study between naproxen and excipients","volume":"302","author":"Rojek","year":"2023","journal-title":"Spectrochim. Acta A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ejpb.2026.115079_b0170","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0022-0248(99)00237-7","article-title":"Tailoring of specific interactions to modify the morphology of naproxen","volume":"205","author":"Tomasko","year":"1999","journal-title":"J. Cryst. Growth"},{"key":"10.1016\/j.ejpb.2026.115079_b0175","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1021\/acs.molpharmaceut.1c00481","article-title":"Balancing Solid-State Stability and Dissolution Performance of Lumefantrine Amorphous Solid Dispersions: The Role of Polymer Choice and Drug-Polymer Interactions","volume":"19","author":"Hiew","year":"2022","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124175","article-title":"Utilizing the allyl-terminated copolymer methoxy(poly(ethylene glycol))-block-poly(jasmine lactone) in the development of amorphous solid dispersions: A comparative study of functionalized and non-functionalized polymer","volume":"657","author":"Di","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms242417155","article-title":"The Study of Amorphous Kaempferol Dispersions Involving FT-IR Spectroscopy","volume":"24","author":"Rosiak","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2026.115079_b0190","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1007\/s11095-009-9970-7","article-title":"Evaluation of drug-polymer miscibility in amorphous solid dispersion systems","volume":"26","author":"Rumondor","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115079_b0195","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.addr.2007.05.008","article-title":"Solubility of sparingly-soluble ionizable drugs","volume":"59","author":"Avdeef","year":"2007","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejpb.2026.115079_b0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105170","article-title":"Establishing virtual bioequivalence and clinically relevant specifications using in vitro biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: Naproxen","volume":"143","author":"Loisios-Konstantinidis","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115079_b0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120845","article-title":"On the usefulness of sink index in characterizing the degree of nonsinkness in dissolution studies","volume":"605","author":"Schver","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0210","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1208\/s12248-022-00760-8","article-title":"Challenges and Strategies for Solubility Measurements and Dissolution Method Development for Amorphous Solid Dispersion Formulations","volume":"25","author":"Hermans","year":"2022","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2026.115079_b0215","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1016\/j.xphs.2016.03.024","article-title":"Non-Sink Dissolution Conditions for Predicting Product Quality and In Vivo Performance of Supersaturating Drug Delivery Systems","volume":"105","author":"Sun","year":"2016","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115079_b0220","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics17020262","article-title":"Roles of Supersaturation and Liquid-Liquid Phase Separation for Enhanced Oral Absorption of Poorly Soluble Drugs from Amorphous Solid Dispersions","volume":"17","author":"Kawakami","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115079_b0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2025.125242","article-title":"Unveiling the impact of preparation methods, matrix\/carrier type selection and drug loading on the supersaturation performance of amorphous solid dispersions","volume":"671","author":"Kapourani","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0230","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1021\/mp5005146","article-title":"The role of drug-polymer hydrogen bonding interactions on the molecular mobility and physical stability of nifedipine solid dispersions","volume":"12","author":"Kothari","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124769","article-title":"Crystallization and intermolecular hydrogen bonding in carbamazepine-polyvinyl pyrrolidone solid dispersions: An experiment and molecular simulation study on drug content variation","volume":"666","author":"Wang","year":"2024","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123440","article-title":"The influence of hydrogen bonding between different crystallization tendency drugs and PVPVA on the stability of amorphous solid dispersions","volume":"646","author":"Wu","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0245","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1021\/acs.molpharmaceut.2c00892","article-title":"Dissolution Mechanisms of Amorphous Solid Dispersions: Role of Drug Load and Molecular Interactions","volume":"20","author":"Deac","year":"2023","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0250","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1021\/mp500660m","article-title":"Drug-polymer-water interaction and its implication for the dissolution performance of amorphous solid dispersions","volume":"12","author":"Chen","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ejpb.2026.115079_b0255","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1002\/jps.24442","article-title":"Drug-polymer interactions at water-crystal interfaces and implications for crystallization inhibition: molecular dynamics simulations of amphiphilic block copolymer interactions with tolazamide crystals","volume":"104","author":"Gao","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115079_b0260","doi-asserted-by":"crossref","first-page":"19","DOI":"10.17219\/pim\/150267","article-title":"Kollidon(R) VA 64 and Soluplus(R) as modern polymeric carriers for amorphous solid dispersions","volume":"52","author":"Strojewski","year":"2022","journal-title":"Polim. Med."},{"key":"10.1016\/j.ejpb.2026.115079_b0265","doi-asserted-by":"crossref","unstructured":"Szafraniec-Szczesny, J., Antosik-Rogoz, A., Kurek, M., Gawlak, K., Gorska, A., Peralta, S., Knapik-Kowalczuk, J., Kramarczyk, D., Paluch, M., Jachowicz, R., 2021. How Does the Addition of Kollidon((R))VA64 Inhibit the Recrystallization and Improve Ezetimibe Dissolution from Amorphous Solid Dispersions? Pharmaceutics 13.","DOI":"10.3390\/pharmaceutics13020147"},{"key":"10.1016\/j.ejpb.2026.115079_b0270","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics16101293","article-title":"Co-Amorphous Solid Dispersion System for Improvement in Dissolution Profile of N-(((1r,4r)-4-((6-fluorobenzo[d]oxazol-2-yl)amino)cyclohexyl)methyl)-2-methylpropane-2-sulfonamide as a Neuropeptide Y5 Receptor Antagonist","volume":"16","author":"Tanaka","year":"2024","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115079_b0275","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/2417292","article-title":"Adsorption of Polyvinylpyrrolidone over the Silica Surface: As Affected by Pretreatment of Adsorbent and Molar Mass of Polymer Adsorbate","volume":"2016","author":"Al-Harbi","year":"2016","journal-title":"International Journal of Polymer Science"}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126001001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T22:22:52Z","timestamp":1778970172000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126001001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":57,"alternative-id":["S0939641126001001"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115079","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanistic insights into dissolution of highly drug-loaded amorphous solid dispersions of a fast-crystallising drug","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115079"}}